_id
694d7149c2e91020a7bbe22c
Ticker
LMRI
Name
Lumexa Imaging Holdings, Inc. Common Stock
Exchange
NASDAQ
Address
4200 Six Forks Road, Raleigh, NC, United States, 27609
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.lumexaimaging.com
Description
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is based in Raleigh, North Carolina.
Last Close
18.49
Volume
924961
Current Price
16.68
Change
-0.95
Last Updated
2026-01-05T09:44:47.110Z
Ipo Date
2025-12-11T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.459
Sentiment Sources
1
Current Quarter
2024-12-31
Revenue
248028000
Cost Of Revenue
226456000
Gross Profit
21572000
Operating Expenses
6321000
Operating Income
15251000
Interest Expense
31387000
Pretax Income
-16026000
Net Income
-25058000
Eps
-0.26497993161407063
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
9032000
EBITDA
28937000
Operating Margin
6.1489025432612445
Total Other Income Expense Net
-31277000
Cash
26131000
Short Term Investments
-
Receivables
135998000
Inventories
-
Total Current Assets
172520000
Property Plant Equipment
201925000
Total Assets
1670564000
Payables
29889000
Short Term Debt
35317000
Long Term Debt
1185080000
Total Liabilities
1508910000
Equity
0
Bs_currency_symbol
USD
Depreciation
13576000
Change In Working Capital
18083000
Cash From Operations
25310000
Capital Expenditures
5870000
Cash From Investing
-5582000
Cash From Financing
-4926000
Net Change In Cash
14802000
Cf_currency_symbol
USD
PE
-
PB
-
ROE
-
ROA
-1.499972464389272
FCF
19440000
Fcf Percent
0.07837824761720451
Piotroski FScore
2
Health Score
34
Deep Value Investing Score
2
Defensive Investing Score
4.5
Dividend Investing Score
3
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
1
Net Net Investing Score
1.5
Quality Investing Score
2.5
Value Investing Score
1
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
248028000
Quarters > 0 > income Statement > cost Of Revenue
226456000
Quarters > 0 > income Statement > gross Profit
21572000
Quarters > 0 > income Statement > operating Expenses
6321000
Quarters > 0 > income Statement > operating Income
15251000
Quarters > 0 > income Statement > interest Expense
31387000
Quarters > 0 > income Statement > pretax Income
-16026000
Quarters > 0 > income Statement > net Income
-25058000
Quarters > 0 > income Statement > eps
-0.26497993161407063
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
94565652
Quarters > 0 > income Statement > income Tax Expense
9032000
Quarters > 0 > income Statement > EBITDA
28937000
Quarters > 0 > income Statement > operating Margin
6.1489025432612445
Quarters > 0 > income Statement > total Other Income Expense Net
-31277000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
26131000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
135998000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
172520000
Quarters > 0 > balance Sheet > property Plant Equipment
201925000
Quarters > 0 > balance Sheet > total Assets
1670564000
Quarters > 0 > balance Sheet > payables
29889000
Quarters > 0 > balance Sheet > short Term Debt
35317000
Quarters > 0 > balance Sheet > long Term Debt
1185080000
Quarters > 0 > balance Sheet > total Liabilities
1508910000
Quarters > 0 > balance Sheet > equity
0
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-25058000
Quarters > 0 > cash Flow > depreciation
13576000
Quarters > 0 > cash Flow > change In Working Capital
18083000
Quarters > 0 > cash Flow > cash From Operations
25310000
Quarters > 0 > cash Flow > capital Expenditures
5870000
Quarters > 0 > cash Flow > cash From Investing
-5582000
Quarters > 0 > cash Flow > cash From Financing
-4926000
Quarters > 0 > cash Flow > net Change In Cash
14802000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.26497993161407063
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-1.499972464389272
Quarters > 0 > ratios > FCF
19440000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.07837824761720451
Quarters > 0 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
948869000
Annuals > 0 > income Statement > cost Of Revenue
852606000
Annuals > 0 > income Statement > gross Profit
96263000
Annuals > 0 > income Statement > operating Expenses
41020000
Annuals > 0 > income Statement > operating Income
55243000
Annuals > 0 > income Statement > interest Expense
136027000
Annuals > 0 > income Statement > pretax Income
-79193000
Annuals > 0 > income Statement > net Income
-94099000
Annuals > 0 > income Statement > eps
-0.9950653118745483
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
94565652
Annuals > 0 > income Statement > income Tax Expense
14906000
Annuals > 0 > income Statement > EBITDA
113995000
Annuals > 0 > income Statement > operating Margin
5.821983856570296
Annuals > 0 > income Statement > total Other Income Expense Net
-134436000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
26131000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
135998000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
172520000
Annuals > 0 > balance Sheet > property Plant Equipment
201925000
Annuals > 0 > balance Sheet > total Assets
1670564000
Annuals > 0 > balance Sheet > payables
29889000
Annuals > 0 > balance Sheet > short Term Debt
35317000
Annuals > 0 > balance Sheet > long Term Debt
1185080000
Annuals > 0 > balance Sheet > total Liabilities
1508910000
Annuals > 0 > balance Sheet > equity
0
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-94099000
Annuals > 0 > cash Flow > depreciation
57161000
Annuals > 0 > cash Flow > change In Working Capital
-2600000
Annuals > 0 > cash Flow > cash From Operations
40727000
Annuals > 0 > cash Flow > capital Expenditures
27773000
Annuals > 0 > cash Flow > cash From Investing
-22283000
Annuals > 0 > cash Flow > cash From Financing
-12499000
Annuals > 0 > cash Flow > net Change In Cash
5945000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.9950653118745483
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-5.632768334526543
Annuals > 0 > ratios > FCF
12954000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.01365204258965147
Annuals > 0 > health Score
20
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
935925000
Annuals > 1 > income Statement > cost Of Revenue
836958000
Annuals > 1 > income Statement > gross Profit
98967000
Annuals > 1 > income Statement > operating Expenses
76522000
Annuals > 1 > income Statement > operating Income
22445000
Annuals > 1 > income Statement > interest Expense
141694000
Annuals > 1 > income Statement > pretax Income
-119249000
Annuals > 1 > income Statement > net Income
-122227000
Annuals > 1 > income Statement > eps
-1.29250946210364
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
94565652
Annuals > 1 > income Statement > income Tax Expense
2978000
Annuals > 1 > income Statement > EBITDA
94581000
Annuals > 1 > income Statement > operating Margin
2.398162245906456
Annuals > 1 > income Statement > total Other Income Expense Net
-141694000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
20186000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
130255000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
166767000
Annuals > 1 > balance Sheet > property Plant Equipment
195805000
Annuals > 1 > balance Sheet > total Assets
1671527000
Annuals > 1 > balance Sheet > payables
24413000
Annuals > 1 > balance Sheet > short Term Debt
37183000
Annuals > 1 > balance Sheet > long Term Debt
1182427000
Annuals > 1 > balance Sheet > total Liabilities
1473101000
Annuals > 1 > balance Sheet > equity
0
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-122227000
Annuals > 1 > cash Flow > depreciation
72136000
Annuals > 1 > cash Flow > change In Working Capital
-4136000
Annuals > 1 > cash Flow > cash From Operations
37514000
Annuals > 1 > cash Flow > capital Expenditures
24007000
Annuals > 1 > cash Flow > cash From Investing
-29657000
Annuals > 1 > cash Flow > cash From Financing
-8769000
Annuals > 1 > cash Flow > net Change In Cash
-912000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.29250946210364
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-
Annuals > 1 > ratios > ROA
-7.312295882746735
Annuals > 1 > ratios > FCF
13507000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.014431711942730454
Annuals > 1 > health Score
20
Valuation > metrics > PE
-0.26497993161407063
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROA
-14.524692789241827
Profitability > metrics > Net Margin
-0.10102891609011885
Profitability > final Score
20
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
0.48590180648039
Risk > final Score
32
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.6457687942827346
Liquidity > metrics > Quick Ratio
2.6457687942827346
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
0
Prev Valuations > 1
0
Prev Valuations > 2
0
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
0
Prev Risks > 1
0
Prev Risks > 2
0
Prev Liquidities > 0
0
Prev Liquidities > 1
0
Prev Liquidities > 2
0
Updated At
2026-01-20T23:12:43.057Z
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is based in Raleigh, North Carolina.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALumexa Imaging Holdings, Inc. - Common Stock (Nasdaq:LMRI) Stock Quote FinancialContent
Read more →A Quick Look at Today's Ratings for Lumexa Imaging(LMRI.US), With a Forecast Between $22 to $23 富途资讯
Read more →Showing 2 of 10
(Last Updated 2024-12-31)
Health Score
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Lumexa Imaging Holdings, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.